These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15044422)

  • 1. Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.
    Warn PA; Sharp A; Guinea J; Denning DW
    J Antimicrob Chemother; 2004 May; 53(5):743-9. PubMed ID: 15044422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J; Armstrong D; Lyman CA; Walsh TJ
    J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.
    Cantón E; Pemán J; Sastre M; Romero M; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2829-32. PubMed ID: 16870779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
    Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
    Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antifungal activity and clinical efficacy of micafungin (funguard)].
    Ikeda F
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of susceptibility testing methods for micafungin: comparison of two microdilution methods].
    Abe M; Ogawa Z; Tanuma H; Yamazaki T; Kume H
    Nihon Ishinkin Gakkai Zasshi; 2008; 49(2):111-8. PubMed ID: 18451592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of micafungin combined with itraconazole against Candida spp.
    Mariné M; Serena C; Pastor J; Quindós G; Carrillo AJ; Guarro J
    Int J Antimicrob Agents; 2007 Nov; 30(5):463-5. PubMed ID: 17698327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
    Ikeda F
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method.
    Pai MP; Jones AL; Mullen CK
    Diagn Microbiol Infect Dis; 2007 May; 58(1):129-32. PubMed ID: 17240112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui E; Persat F; Monier MF; Borel E; Piens MA; Picot S
    Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.
    Mikamo H; Sato Y; Tamaya T
    J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.